HKU on Coronavirus (Mar 1-Apr 13, 2021)


HKU in the news (Mar1-Apr 13)

Apr 7 HKUMed study reveals immunogenic epitope on virus spike protein for higher efficiency COVID-19 vaccine

Apr 5 HKUMed co-led study reveals a globally accessible and inexpensive drug effective against lethal inflammation from COVID-19 in animal models (link)

Apr 4 HKUMed initiates allergy research on COVID-19 using blood tests (Professor Philip Li)

Mar 22 HKUMed conducts clinical trial on switching two vaccines to find if switching jabs could alleviate severe side effects (Professor Ivan Hung) (link)

Mar 21 HKUMed study to recruit 200 secondary students to take COVID-19 vaccine (Professor Lau Yu-Lung) (link)

Mar 20 HKU receives further US$4.89 million funding from Coalition for Epidemic Preparedness Innovations for developing COVID-19 nasal spray vaccine (link)

Mar 18 HKUMed co-developed COVID-19 vaccine arrives Hong Kong for first-phase clinical trial (Professor Yuen Kwok-yung) (link)

Mar 17 HKUMed research finds leprosy drug holds promise treating COVID-19 (Professor Yuen Kwok-yung) (link)

Mar 16 HKUMed study discovers clofazimine for treating malaria and influenza effective against COVID-19 and is relatively safe and cheap (Professor Yuen Kwok-yung) (link)

Mar 5 HKUMed research reveals COVID-19 infection by nasal turbinate cannot be completely protected by systemic antibody or vaccine, showing risk of reinfection (Professor Chen Zhiwei) (link)

Mar 1 HKU Engineering-led team has increased its COVID-19 sewage monitoring capacity to about 170 samples per week (link)